BHVN as reported
- Net Income
- −$587M
Net Income · −23% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- −$512M
Free Cash Flow · −21% year on year · trailing twelve months to Q2 2026
- EPS
- −$4.55
EPS · −40% year on year · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net Income | −$587M | −23% | Q2 2026 |
| EPS | −$4.55 | −40% | Q2 2026 |
| ROE | −544% | n/a | Q2 2026 |
| ROA | −163% | n/a | Q2 2026 |
| Free Cash Flow | −$512M | −21% | Q2 2026 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Biohaven Ltd. (BHVN) - Net IncomeNet IncomeBiohaven Ltd. (BHVN)